Previous close | 0.7500 |
Open | N/A |
Bid | 0.0000 |
Ask | 2.5500 |
Strike | 370.00 |
Expiry date | 2024-05-17 |
Day's range | 0.7500 - 0.7500 |
Contract range | N/A |
Volume | |
Open interest | 1 |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.